Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2014, Article ID 913902, 6 pages
http://dx.doi.org/10.1155/2014/913902
Clinical Study

The First Fifty ABO Blood Group Incompatible Kidney Transplantations: The Rotterdam Experience

1Department of Internal Medicine, Division of Nephrology & Transplantation, Erasmus Medical Center, D414, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands
2Department of Hematology, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands
3Department of Surgery, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands

Received 24 November 2013; Revised 20 December 2013; Accepted 21 December 2013; Published 6 February 2014

Academic Editor: Kazuhiko Yamada

Copyright © 2014 Madelon van Agteren et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. E. Breimer, J. Mölne, G. Nordén, L. Rydberg, G. Thiel, and C. T. Svalander, “Blood group A and B antigen expression in human kidneys correlated to A1/A2/B, Lewis, and secretor status,” Transplantation, vol. 82, no. 4, pp. 479–485, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Rydberg, “ABO-incompatibility in solid organ transplantation,” Transfusion Medicine, vol. 11, no. 4, pp. 325–342, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. L. S. Cummings, J. S. Hawksworth, J.-F. Guerra et al., “Successful ABO incompatible kidney transplant after an isolated intestinal transplant,” Transplantation, vol. 91, no. 10, pp. e73–e74, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. B. H. Chung, J. Y. Lee, S. H. Kang et al., “Comparison of clinical outcome between high and low baseline anti-ABO antibody titers in ABO-incompatible kidney transplantation,” Renal Failure, vol. 33, no. 2, Article ID 552149, pp. 150–158, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Tydén, G. Kumlien, and I. Fehrman, “Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab,” Transplantation, vol. 76, no. 4, pp. 730–731, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Genberg, G. Kumlien, L. Wennberg, U. Berg, and G. Tydén, “ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up,” Transplantation, vol. 85, no. 12, pp. 1745–1754, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Tydén, J. Donauer, J. Wadström et al., “Implementation of a protocol for ABO-incompatible kidney transplantation—a three-center experience with 60 consecutive transplantations,” Transplantation, vol. 83, no. 9, pp. 1153–1155, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. M. Flint, R. G. Walker, C. Hogan et al., “Successful ABO-incompatible kidney transplantation with antibody removal and standard immunosuppression,” American Journal of Transplantation, vol. 11, no. 5, pp. 1016–1024, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Genberg, G. Kumlien, L. Wennberg, and G. Tydén, “Long-term results of ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab,” Transplantation, vol. 84, no. 12, pp. S44–S47, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Wilpert, K.-G. Fischer, P. Pisarski et al., “Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis,” Nephrology, Dialysis, Transplantation, vol. 25, no. 11, pp. 3778–3786, 2010. View at Google Scholar · View at Scopus
  11. S. Fuchinoue, Y. Ishii, T. Sawada et al., “The 5-year outcome of ABO-incompatible kidney transplantation with rituximab induction,” Transplantation, vol. 91, no. 8, pp. 853–857, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Teschner, D. Stippel, R. Grunenberg et al., “ABO-incompatible kidney transplantation using regenerative selective immunoglobulin adsorption,” Journal of Clinical Apheresis, vol. 27, no. 2, pp. 51–60, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Oettl, J. Halter, A. Bachmann et al., “ABO blood group-incompatible living donor kidney transplantation: a prospective, single-centre analysis including serial protocol biopsies,” Nephrology Dialysis Transplantation, vol. 24, no. 1, pp. 298–303, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Toki, H. Ishida, K. Setoguchi et al., “Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: long-term impact and risk factors,” American Journal of Transplantation, vol. 9, no. 3, pp. 567–577, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Uchida, Y. MacHida, T. Iwai et al., “Clinical outcome of ABO-incompatible living unrelated donor kidney transplantation,” Urologia Internationalis, vol. 86, no. 3, pp. 307–314, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Toki, H. Ishida, S. Horita, Y. Yamaguchi, and K. Tanabe, “Blood group O recipients associated with early graft deterioration in living ABO-incompatible kidney transplantation,” Transplantation, vol. 88, no. 10, pp. 1186–1193, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Lawrence, J. W. Galliford, M. K. Willicombe et al., “Antibody removal before ABO-incompatible renal transplantation: how much plasma exchange is therapeutic?” Transplantation, vol. 92, no. 10, pp. 1129–1133, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Wilpert, M. Geyer, S. Teschner et al., “ABO-incompatible kidney transplantation-proposal of an intensified apheresis strategy for patients with high initial isoagglutinine titers,” Journal of Clinical Apheresis, vol. 22, no. 6, pp. 314–322, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Kumlien, J. Wilpert, J. Säfwenberg, and G. Tydén, “Comparing the tube and gel techniques for ABO antibody titration, as performed in three European centers,” Transplantation, vol. 84, no. 12, pp. S17–S19, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. E. Fidler, J. M. Gloor, D. J. Lager et al., “Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation,” American Journal of Transplantation, vol. 4, no. 1, pp. 101–107, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. R. A. Montgomery and J. E. Locke, “ABO-incompatible transplantation: less may be more,” Transplantation, vol. 84, no. 12, pp. S8–S9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Habicht, V. Bröker, C. Blume et al., “Increase of infectious complications in ABO-incompatible kidney transplant recipients—a single centre experience,” Nephrology Dialysis Transplantation, vol. 26, no. 12, pp. 4124–4131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Sharif, N. Alachkar, S. Bagnasco et al., “Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients,” Clinical Journal of the American Society of Nephrology, vol. 7, pp. 1320–1327, 2012. View at Google Scholar
  24. N. Kohei, T. Hirai, K. Omoto, H. Ishida, and K. Tanabe, “Chronic antibody-mediated rejection is reduced by targeting B-cell immunity during an introductory period,” American Journal of Transplantation, vol. 12, no. 2, pp. 469–476, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Oettl, E. Zuliani, A. Gaspert, H. Hopfer, M. Dickenmann, and T. Fehr, “Late steroid withdrawal after ABO blood group-incompatible living donor kidney transplantation: high rate of mild cellular rejection,” Transplantation, vol. 89, no. 6, pp. 702–706, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. J. I. Roodnat, J. van de Wetering, F. H. Claas, J. Ijzermans, and W. Weimar, “Persistently low transplantation rate of ABO blood type O and highly sensitised patients despite alternative transplantation programs,” Transplant International, vol. 25, pp. 987–993, 2012. View at Google Scholar
  27. J. I. Roodnat, J. A. Kal-van Gestel, W. Zuidema et al., “Successful expansion of the living donor pool by alternative living donation programs,” American Journal of Transplantation, vol. 9, no. 9, pp. 2150–2156, 2009. View at Publisher · View at Google Scholar · View at Scopus